MT5 opnMAX Midas
- Experts
- Nelson Rodrigo Caldeira Patrao
- 버전: 7.53
- 활성화: 5
opnMAX Midas is a high-precision trading algorithm engineered specifically for the unique volatility of the Gold (XAUUSD) market. Designed for traders who demand professional-grade execution, Midas focuses on the critical transition periods of global market sessions.
By identifying institutional liquidity zones within a precise lookback window, the EA seeks to capitalize on intraday momentum shifts that occur when major financial hubs come online.
Key Features
-
Precision Timing: Triggers specific calculations just before session open, ensuring the algorithm captures the most relevant price data.
-
Dynamic Range Analysis: Utilizes a proprietary structural scan to define market "pivots" before the daily volume surge.
-
Risk Management: Built-in fixed structural Stop Loss logic with an adjustable Risk:Reward (RR) engine to optimize capital growth.
-
One-Strike Logic: Designed to capture the primary move of the session, executing only the highest-probability touch per cycle to preserve equity.
-
Zero Latency Execution: Uses direct market touch technology to avoid the "slippage" often associated with stagnant pending orders during high-volatility news or openings.
Specifications
-
Primary Asset: XAUUSD (Gold).
-
Timeframe: H1 (1 Hour).
-
Strategy Type: Institutional Session Breakout / Mean Reversion Hybrid.
"Midas doesn't chase the market; it waits for the market to reveal its hand at the open."
⛔ Financial Disclaimer
Trading foreign exchange, indices, or commodities on margin carries a high level of risk and may not be suitable for all investors. The high degree of leverage can work against you as well as for you. Before deciding to invest in the financial markets, you should carefully consider your investment objectives, level of experience, and risk appetite. The possibility exists that you could sustain a loss of some or all of your initial investment; therefore, you should not invest money that you cannot afford to lose. Past performance, whether live or via backtesting, is not indicative of future results.
